Clincosm LogoSign in Get a demo

myeloid malignancy

Showing 1 - 14 of 14
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myeloid Malignancy, Acute Myeloid Leukemia Trial in Cleveland (Venetoclax, Decitabine)

Not yet recruiting
  • Myeloid Malignancy
  • Acute Myeloid Leukemia
  • Cleveland, Ohio
    University Hospitals Seidman Cancer, Case Comprehensive Cancer C
Nov 8, 2023

Molecular Services and EMR-Lab Integration Application for

Not yet recruiting
  • Advanced Cancer
  • +2 more
  • Comprehensive Genomic Profile testing; ELIA software; Molecular Genetic Pathologist consultation
  • limited genetic testing or no testing
  • Rock Hill, South Carolina
    Carolina Blood and Cancer Care Associates
Oct 18, 2023

Myeloid Malignancy, Acute Myeloid Leukemia, MDS Trial in Rochester (Telehealth Serious Illness Care Program, Education Control)

Not yet recruiting
  • Myeloid Malignancy
  • +4 more
  • Telehealth Serious Illness Care Program
  • Education Control
  • Rochester, New York
    University of Rochester
May 24, 2023

Hypomethylating Agent, Venetoclax, Myeloid Malignancy Trial in Shanghai (Venetoclax, Azacitidine or decitabine)

Recruiting
  • Hypomethylating Agent
  • +2 more
  • Shanghai, Shanghai, China
    Shanghai Jiao Tong University School of Medicine Affilated Shang
May 2, 2023

Hematologic Malignancy, Myeloid Malignancy Trial in Memphis (Ruxolitinib, Mesna, Anti-thymocyte globulin (ATG))

Recruiting
  • Hematologic Malignancy
  • Myeloid Malignancy
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Nov 7, 2022

Leukemia, Myeloid, Acute, MDS, Hematopoietic Stem Cell Transplantation Trial in Shanghai (Venetoclax plus RIC)

Not yet recruiting
  • Leukemia, Myeloid, Acute
  • +3 more
  • Venetoclax plus RIC
  • Shanghai, Shanghai, China
    Shanghai General Hospital
Oct 12, 2022

Myeloid Malignancy, MDS, Myelofibrosis Trial in Boston (Navitoclax, Venetoclax, Decitabine)

Recruiting
  • Myeloid Malignancy
  • +4 more
  • Boston, Massachusetts
  • +2 more
Jul 21, 2022

Lymphoid Leukemia, Acute, Myeloid Malignancy, Plasma Cell Tumor Trial in Miami (T-cell Receptor a/ß Depleted Donor Lymphocyte

Recruiting
  • Lymphoid Leukemia, Acute
  • +2 more
  • T-cell Receptor α/β Depleted Donor Lymphocyte Infusions
  • Miami, Florida
    Miami Cancer Institute at Baptist Health, Inc
May 24, 2022

Myeloid Malignancy Trial in United States (APR-246, Venetoclax, Azacitidine)

Completed
  • Myeloid Malignancy
  • New Haven, Connecticut
  • +7 more
Jan 18, 2022

Relapsed/Refractory Acute Myeloid Leukaemia, Myeloid Malignancy Trial in China (APG-2575, reduced-dose HHT, standard-dose HHT)

Recruiting
  • Relapsed/Refractory Acute Myeloid Leukaemia
  • Myeloid Malignancy
  • Beijing, Beijing, China
  • +9 more
Jan 10, 2022

Myeloid Malignancy Trial in Detroit (azacitidine)

Recruiting
  • Myeloid Malignancy
  • Detroit, Michigan
    Henry ford hospital
Dec 23, 2021

MDS, Acute Myeloid Leukemia, Myeloid Malignancy Trial in Guangzhou (Sodium stibogluconate)

Recruiting
  • Myelodysplastic Syndromes
  • +5 more
  • Sodium stibogluconate
  • Guangzhou, Guangdong, China
    First Affiliated Hospital of Jinan University
Jun 5, 2021

P53 Mutation, Myeloid Malignancy, MDS Trial in Shanghai (Decitabine, Arsenic Trioxide)

Recruiting
  • P53 Mutation
  • +3 more
  • Shanghai, Shanghai, China
    Hematological department, Shanghai Institute of Hematology, Ruij
Apr 20, 2021

Myeloid Malignancy, Bone Marrow Failure Syndrome, Transfusion-dependent Red Blood Cell (RBC) Defect Trial in San Francisco

Terminated
Has Results
  • Myeloid Malignancy
  • +5 more
  • San Francisco, California
    University of California, San Francisco
Feb 25, 2020